CVS Health Corp. buy Wolfe Research
Summary
This prediction ended on 12.02.26 with a price of €64.96. The BUY prediction by Wolfe_Research finished with a performance of 21.67%. Wolfe_Research has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. Wolfe_Research has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CVS Health Corp. | 4.175% | 4.175% | 8.340% |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% |
Comments by Wolfe_Research for this prediction
In the thread CVS Health Corp. diskutieren
In the thread Trading CVS Health Corp.
Current prediction by Wolfe_Research for CVS Health Corp.
Stopped prediction by Wolfe_Research for CVS Health Corp.
CVS Health Corp.
12.09.23
12.09.24
13.09.24
